{"id":"W2285786982","doi":"10.1182/blood.v122.21.3961.3961","title":"A Phase I Study Of Nilotinib As a c-Kit Inhibitor Combined With Re-Induction Chemotherapy For Relapsed and Refractory c-Kit Positive Acute Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Cytarabine; Medicine; Nilotinib; Etoposide; Mitoxantrone; Internal medicine; Gastroenterology; Myeloid leukemia; Refractory (planetary science); Chemotherapy; Phases of clinical research; Pharmacology; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001186123,0.00152722,0.002887451,0.0005998317,0.0004726019,0.001133126,0.001399676,0.001095145,0.002601604],"category_scores_gemma":[0.0005662353,0.0006240163,0.001349493,0.0004963254,0.0009965369,0.0007328843,0.0004209151,0.003488415,0.000989921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007980646,"about_ca_system_score_gemma":0.001361113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008808807,"about_ca_topic_score_gemma":0.001976571,"domain_scores_codex":[0.9994797,0.0002153281,0.00003263207,0.0001054758,0.00004931774,0.000117532],"domain_scores_gemma":[0.9993789,0.00006732214,0.00008493693,0.00007087825,0.00004263938,0.0003552565],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4968146,0.2187213,0.005421472,0.001406159,0.001851852,0.001135231,0.0004307162,0.003966278,0.1640574,0.0005182108,0.00459048,0.1010864],"study_design_scores_gemma":[0.3113995,0.6701614,0.005630739,0.00003543877,0.0004404778,0.0004699497,0.00005795726,0.001065604,0.008607167,0.0001435606,0.001948861,0.00003945506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931079,0.001628367,0.0005437271,0.0003899954,0.0001585363,0.002118121,0.0006300064,0.0001089945,0.001314383],"genre_scores_gemma":[0.990348,0.001674532,0.001412089,0.0005744819,0.0001826657,0.002010094,0.001548438,0.00003173739,0.002217957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002887451,"threshold_uncertainty_score":0.008703172,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0123737816391059,"score_gpt":0.276844450004873,"score_spread":0.264470668365767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}